Sarita Shah
Professor
Faculty, Epidemiology
Jointly Appointed, Global Health
My research and public health work have focused on drug-resistant TB and TB/HIV epidemiology for the past twenty years in multiple high-burden settings throughout sub-Saharan Africa and Asia. A major interest is TB prevention through multi-disciplinary research that examines TB transmission dynamics, host susceptibility to TB infection and disease, novel drugs for TB preventive therapy, and real-world effectiveness of TB preventive therapy in high-risk groups.
I serve as the Co-director of the Clinical & Population Sciences Core for the Emory/Georgia TB Center where I work with partners across Emory, University of Georgia, metro Atlanta, and internationally to expand TB research and training opportunities. Mentoring the next generation of TB scientists is integral to my research mission with trainees involved in all aspects, from study design to implementation, analysis,and dissemination. My work in Atlanta is centered on the Emory COVID-19 Response Collaborative (ECRC) whose mission is to bring together Rollins faculty, staff and students to support the Georgia Department of Public Health's response to emerging public health threats through partnerships with local health departments.
Through my role as a TB expert for the Global Fund, World Health Organization (WHO), and US HIV treatment guidelines, I synthesize evidence to inform policy and programming at global, regional, and national levels. My research is funded by the NIH, CDC, and the Bill & Melinda Gates Foundation, and has been recognized through election to the American Society for Clinical Investigation (ASCI), Society for Epidemiologic Research (Roger Detels Award in Infectious Disease Epidemiology), The Union Scientific Prize, and several CDC awards for research and service. Media coverage has included the New York Times, National Public Radio, CNN, Wall Street Journal, Washington Post, and others.
I received my undergraduate and MD degree from Johns Hopkins University, followed by clinical training in Internal Medicine and MPH at Columbia University's New York-Presbyterian Hospital and Mailman School of Public Health. I served as an Epidemic Intelligence Service (EIS) officer at the U.S. Centers for Disease Control and Prevention (CDC) in the Division of TB Elimination, where I later served as the Associate Chief for Science and Team Lead (2012-2020). I joined the Emory faculty in 2020 and remain involved with TB/HIV research with the CDC in several countries. I am also a clinical care provider for people living with HIV, initially in the Bronx, NY, and currently at the Atlanta Veterans Affairs (VA) Medical Center, GA.
A complete list of my published work can be found here.
Contact Information
1518 CLIFTON RD
ATLANTA , GA
1518002
Phone: (404) 727-7326
Fax: (404) 727-4590
Email: sarita.shah@emory.edu
Areas of Interest
- Epidemiology
- Global Health
- Infectious Disease
- Public Health Practice
- Tuberculosis
Education
- BA 1996, Johns Hopkins University
- MD 2000, Johns Hopkins School of Medicine
- MPH 2004, Columbia University Mailman School of Public Health
Affiliations & Activities
Complete List of Published Work in MyBibliography: https://www.ncbi.nlm.nih.gov/myncbi/1ZkcT7n65lvQo/bibliography/public/
Publications
- Weyenga H, Karanja M, Katana AK, Ng’ang’a LW, Sirengo M, Ondondo RO, Onyango E, Wambugu C, Masini E, Ngugi EW, Shah NS, Pathmanathan I, Maloney S, De Cock KM, 2021, Can Tuberculosis Preventive Therapy among People Living with HIV be Scaled up Rapidly? Lessons Learned in Kenya, 2014-2018, Int J Tuberc Lung Dis, 21, 367-372
- Labgold K, Hamid S, Shah S, Gandhi NR, Chamberlain A, Khan F, Khan S, Smith S, Williams S, Lash TL, Collin LJ, 2021, Estimating the Unknown: Greater Racial and Ethnic Disparities in COVID-19 Burden After Accounting for Missing Race and Ethnicity Data, Epidemiology, 32, 157-161
- Yoon JC, Prieto J, Shah NS, Clark J, Chamberlain A, Holland DP, 2021, Implementation of close contact elicitation at time of COVID-19 testing – Atlanta, GA, October-November 2020, J Public Health , May,
- Velen K, Podewils LJ, Shah NS, Lewis J, Dinake T, Churchyard G, Reichler M, Charalambous S, 2021, Performance of GeneXpert MTB/RIF for diagnosing tuberculosis among symptomatic household contacts of source TB cases in South Africa, Open Forum Infect Dis, ,
- Baliashvili D, Gandhi NR, Kim S, Hughes M, Mave V, Mendoza-Ticona A, Narunsky K, Poongulali S, Badal-Faesen S, Upton C, Naini L, Smith E, Gupta A, Churchyard G, Swindells S, Hesseling A, Shah NS for ACTG A5300/IMPAACT I2003 PHOENIx Feasibility study team, 2021, Resistance to Mycobacterium tuberculosis infection among household contacts of patients with multidrug-resistant tuberculosis from eight countries, Clin Infect Dis, ,
- Telford CT, Bystrom C, Fox T, Holland D, Wiggins-Benn S, Mandani A, McCloud M, Shah NS, 2020, Assessment of Infection Prevention and Control Protocols, Procedures, and Implementation in Response to the COVID-19 Pandemic in Twenty Long-term Care Facilities in Fulton County, Georgia, J Am Geriatric Soc , ,
- Telford CT, Onwubiko U, Holland DP, Turner K, Prieto J, Smith S, Yoon J, Brown W, Chamberlain A, Gandhi N, Khan S, Williams S, Khan F, Shah NS, 2020, Preventing COVID-19 Outbreaks in Long-Term Care Facilities Through Preemptive Testing of Residents and Staff Members — Fulton County, Georgia, March–May 2020, MMWR Morb Mortal Wkly Rep, 69, 1296-1299
- Nelson KN, Jenness SM, Mathema B, Lopman BA, Auld SC, Shah NS, Brust JCM, Ismail N, Omar SV, Brown TS, Allana S, Campbell A, Moodley P, Mlisana K, Gandhi NR., 2020, Social Mixing and Clinical Features Linked With Transmission in a Network of Extensively Drug-resistant Tuberculosis Cases in KwaZulu-Natal, South Africa. , Clin Infect Dis ., 70, 2396-240
- Smith JP, Gandhi NR, Shah NS, Mlisana K, Moodley P, Johnson BA, Allana S, Campbell A, Nelson KN, Master I, Brust JCM., 2020, The Impact of Concurrent Antiretroviral Therapy and MDR-TB Treatment on Adverse Events. , J Acquir Immune Defic Syndr , 83, 47-55
- Suryavanshi N, Murrill M, Gupta A, Hughes M, Hesseling A, Kim S, Naini L, Jones L, Smith B, Gupte N, Dawson R, Mave V, Meshram S, Mendoza-Ticona A, Sanchez J, Kumarasamy N, Comins K, Conradie F, Shenje J, Nerette Fontain S, Garcia-Prats A, Asmelash A, Nedsuwan S, Mohapi L, Lalloo U, Cristina Garcia Ferreira A, Okeyo E, Swindells S, Churchyard G, Shah NS., 2020, Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional Study. , Clin Infect Dis , 70, 436-445
- Peterson ML, Gandhi NR, Clennon J, Nelson KN, Morris N, Ismail N, Allana S, Campbell A, Brust JCM, Auld SC, Mathema B, Mlisana K, Moodley P, Shah NS, 2019, Extensively drug-resistant tuberculosis 'hotspots' and sociodemographic associations in Durban, South Africa., Int J Tuberc Lung Dis, 23, 720-727
- Shah NS, Auld SC, Brust JC, Mathema B, Ismail N, Moodley P, Mlisana K, Allana S, Campbell A, Mthiyane T, Morris N, Mpangase P, van der Meulen H, Omar SV, Brown TS, Narechania A, Shaskina E, Kapwata T, Kreiswirth B, Gandhi NR, 2017, Transmission of Extensively Drug-Resistant Tuberculosis in South Africa. , N Engl J Med , 376, 243-253